Skip to main content
Inpatient Procedure Code

XW04387

Introduction of Lurbinectedin into Central Vein, Percutaneous Approach, New Technology Group 7

Introduce Lurbinectedin in Central Vein, Perc, New Tech 7

Axis Breakdown

Every ICD-10-PCS code is exactly seven characters, one per axis. Each character's meaning is defined by its position in the code.

PositionValueMeaning
1
SectionX

New Technology

2
Body SystemW

Anatomical Regions

3
Root Operation0

Introduction

Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

4
Body Part4

Central Vein

5
Approach3

Percutaneous

6
Device / Substance / Technology8

Lurbinectedin

7
New Technology Group7

New Technology Group 7

Related Codes

Same operation — other Body Part

Same table and root operation, differing only in the body part character.

XW03387 — Introduction of Lurbinectedin into Peripheral Vein, Percutaneous Approach, New Technology Group 7

Same operation — other Device

Same table and root operation, differing only in the device character.

XW04357 — Introduction of Narsoplimab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 7, XW04367 — Introduction of Terlipressin into Central Vein, Percutaneous Approach, New Technology Group 7, XW04377 — Introduction of Trilaciclib into Central Vein, Percutaneous Approach, New Technology Group 7, XW043A7 — Introduction of Ciltacabtagene Autoleucel into Central Vein, Percutaneous Approach, New Technology Group 7, XW043B7 — Introduction of Amivantamab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 7, XW043C7 — Introduction of Autologous Engineered Chimeric Antigen Receptor T-cell Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7, XW043G7 — Introduction of Allogeneic Engineered Chimeric Antigen Receptor T-cell Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7, XW043H7 — Introduction of Axicabtagene Ciloleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7, +5 more

Same operation — other Qualifier

Same table and root operation, differing only in the qualifier character.

XW04388 — Introduction of Treosulfan into Central Vein, Percutaneous Approach, New Technology Group 8, XW0438A — Introduction of Obecabtagene Autoleucel into Central Vein, Percutaneous Approach, New Technology Group 10

Contextual Map

Every relationship of XW04387 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

PCS table

  • XW0[PCS table]
  • [object Object] — Section: [object Object] [Section]: “[object Object]”
  • [object Object] — Body System: [object Object] [Body System]: “[object Object]”
  • [object Object] — Operation: [object Object] [Operation]: “[object Object]”

Nearest codes

  • XW03387 — Introduction of Lurbinectedin into Peripheral Vein, Percutaneous Approach, New Technology Group 7 [One axis away]
  • XW04357 — Introduction of Narsoplimab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 7 [One axis away]
  • XW04367 — Introduction of Terlipressin into Central Vein, Percutaneous Approach, New Technology Group 7 [One axis away]
  • XW04377 — Introduction of Trilaciclib into Central Vein, Percutaneous Approach, New Technology Group 7 [One axis away]
  • XW04388 — Introduction of Treosulfan into Central Vein, Percutaneous Approach, New Technology Group 8 [One axis away]
  • XW0438A — Introduction of Obecabtagene Autoleucel into Central Vein, Percutaneous Approach, New Technology Group 10 [One axis away]
  • XW043A7 — Introduction of Ciltacabtagene Autoleucel into Central Vein, Percutaneous Approach, New Technology Group 7 [One axis away]
  • XW043B7 — Introduction of Amivantamab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 7 [One axis away]

Change history

  • FY2027 — Removed from the code set [Change history]

Valid now — removed for FY2027, not valid on or after October 1, 2026

Change history

  • FY2027 — 2026-10-01
    Removed from the code set
    Introduction of Lurbinectedin into Central Vein, Percutaneous Approach, New Technology Group 7
    FY2027 changes